Anti-toxoplasma, antioxidant and cytotoxic activities of Pleopeltis crassinervata (Fée) T. Moore hexane fraction

The apicomplexan parasite Toxoplasma gondii (T. gondii) causes toxoplasmosis in humans. Pyrimethamine and sulfadiazine that are the drugs of choice to treat the disease, produce severe side effects as well as failure treatments because of drug resistance; thus, novel anti-Toxoplasma compounds are ne...

Full description

Bibliographic Details
Main Authors: Jhony Anacleto-Santos, Perla López-Camacho, Ricardo Mondragón-Flores, Elisa Vega-Ávila, Gustavo Basurto Islas, Mónica Mondragón-Castelán, Elba Carrasco-Ramírez, Norma Rivera-Fernández
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Saudi Journal of Biological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S1319562X19303328
id doaj-19cf09a9074b419288dcecc52ee78ce3
record_format Article
spelling doaj-19cf09a9074b419288dcecc52ee78ce32020-11-25T01:57:54ZengElsevierSaudi Journal of Biological Sciences1319-562X2020-03-01273812819Anti-toxoplasma, antioxidant and cytotoxic activities of Pleopeltis crassinervata (Fée) T. Moore hexane fractionJhony Anacleto-Santos0Perla López-Camacho1Ricardo Mondragón-Flores2Elisa Vega-Ávila3Gustavo Basurto Islas4Mónica Mondragón-Castelán5Elba Carrasco-Ramírez6Norma Rivera-Fernández7Doctorado en Ciencias Biológicas y de la Salud, Departamento de Ciencias Naturales e Ingeniería, Universidad Autónoma Metropolitana, Cuajimalpa 05370, CDMX, MéxicoDepartamento de Ciencias Naturales e Ingeniería, Universidad Autónoma Metropolitana, Cuajimalpa 05370, CDMX, MéxicoDepartamento de Bioquímica, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Col Zacatenco 07360, CDMX, MéxicoDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana, Iztapalapa 09340, CDMX, MéxicoDepartamento de Ingenierías, Química, Electrónica y Biomédica, Universidad de Guanajuato Mex, Campus León, MéxicoDepartamento de Bioquímica, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Col Zacatenco 07360, CDMX, MéxicoDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, 04510 CDMX, MéxicoDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, 04510 CDMX, México; Corresponding author.The apicomplexan parasite Toxoplasma gondii (T. gondii) causes toxoplasmosis in humans. Pyrimethamine and sulfadiazine that are the drugs of choice to treat the disease, produce severe side effects as well as failure treatments because of drug resistance; thus, novel anti-Toxoplasma compounds are needed and natural compounds can be a good source to obtain them, as medicinal plants have been used to control other apicomplexan parasites. Pleopeltis crassinervata (P. crassinervata) is a fern used in some rural areas of Mexico to treat among other malaises, mouth ulcers, gastrointestinal problems and parasites. Therefore, the efficacy of extracts and fractions obtained from P. crassinervata fronds was evaluated on the viability of T. gondii RH strain tachyzoites by the Stytox green method. RH is the prototypical type 1 Toxoplasma strain, isolated for the first time from the brain of a patient boy named R. H. Its phytochemical profile, MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, Hep-2 cytotoxicity and antioxidant activity by ABTS (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) and DPPH (2,2-diphenyl-1-picrylhydrazyl) methods, were also assessed. Hexane fraction exhibited the highest anti-Toxoplasma activity with an IC50 of 16.90 µg/mL. This fraction did not show antioxidant activity and contained at least 2 terpenoid type compounds with retention factor (Rf) of 0.75 and 0.86. The fraction was not toxic to the host cells in doses up to 50 µg/mL. P. crassinervata frond hexane fraction seems to be a good candidate to obtain possible anti-Toxoplasma compounds. This study is the first to report the biological, antioxidant and cytotoxic activity of P. crassinervata fern. Keywords: Toxoplasma gondii, Natural compounds, Pleopeltis crassinervata, Hexane fraction, Terpenoidshttp://www.sciencedirect.com/science/article/pii/S1319562X19303328
collection DOAJ
language English
format Article
sources DOAJ
author Jhony Anacleto-Santos
Perla López-Camacho
Ricardo Mondragón-Flores
Elisa Vega-Ávila
Gustavo Basurto Islas
Mónica Mondragón-Castelán
Elba Carrasco-Ramírez
Norma Rivera-Fernández
spellingShingle Jhony Anacleto-Santos
Perla López-Camacho
Ricardo Mondragón-Flores
Elisa Vega-Ávila
Gustavo Basurto Islas
Mónica Mondragón-Castelán
Elba Carrasco-Ramírez
Norma Rivera-Fernández
Anti-toxoplasma, antioxidant and cytotoxic activities of Pleopeltis crassinervata (Fée) T. Moore hexane fraction
Saudi Journal of Biological Sciences
author_facet Jhony Anacleto-Santos
Perla López-Camacho
Ricardo Mondragón-Flores
Elisa Vega-Ávila
Gustavo Basurto Islas
Mónica Mondragón-Castelán
Elba Carrasco-Ramírez
Norma Rivera-Fernández
author_sort Jhony Anacleto-Santos
title Anti-toxoplasma, antioxidant and cytotoxic activities of Pleopeltis crassinervata (Fée) T. Moore hexane fraction
title_short Anti-toxoplasma, antioxidant and cytotoxic activities of Pleopeltis crassinervata (Fée) T. Moore hexane fraction
title_full Anti-toxoplasma, antioxidant and cytotoxic activities of Pleopeltis crassinervata (Fée) T. Moore hexane fraction
title_fullStr Anti-toxoplasma, antioxidant and cytotoxic activities of Pleopeltis crassinervata (Fée) T. Moore hexane fraction
title_full_unstemmed Anti-toxoplasma, antioxidant and cytotoxic activities of Pleopeltis crassinervata (Fée) T. Moore hexane fraction
title_sort anti-toxoplasma, antioxidant and cytotoxic activities of pleopeltis crassinervata (fée) t. moore hexane fraction
publisher Elsevier
series Saudi Journal of Biological Sciences
issn 1319-562X
publishDate 2020-03-01
description The apicomplexan parasite Toxoplasma gondii (T. gondii) causes toxoplasmosis in humans. Pyrimethamine and sulfadiazine that are the drugs of choice to treat the disease, produce severe side effects as well as failure treatments because of drug resistance; thus, novel anti-Toxoplasma compounds are needed and natural compounds can be a good source to obtain them, as medicinal plants have been used to control other apicomplexan parasites. Pleopeltis crassinervata (P. crassinervata) is a fern used in some rural areas of Mexico to treat among other malaises, mouth ulcers, gastrointestinal problems and parasites. Therefore, the efficacy of extracts and fractions obtained from P. crassinervata fronds was evaluated on the viability of T. gondii RH strain tachyzoites by the Stytox green method. RH is the prototypical type 1 Toxoplasma strain, isolated for the first time from the brain of a patient boy named R. H. Its phytochemical profile, MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, Hep-2 cytotoxicity and antioxidant activity by ABTS (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) and DPPH (2,2-diphenyl-1-picrylhydrazyl) methods, were also assessed. Hexane fraction exhibited the highest anti-Toxoplasma activity with an IC50 of 16.90 µg/mL. This fraction did not show antioxidant activity and contained at least 2 terpenoid type compounds with retention factor (Rf) of 0.75 and 0.86. The fraction was not toxic to the host cells in doses up to 50 µg/mL. P. crassinervata frond hexane fraction seems to be a good candidate to obtain possible anti-Toxoplasma compounds. This study is the first to report the biological, antioxidant and cytotoxic activity of P. crassinervata fern. Keywords: Toxoplasma gondii, Natural compounds, Pleopeltis crassinervata, Hexane fraction, Terpenoids
url http://www.sciencedirect.com/science/article/pii/S1319562X19303328
work_keys_str_mv AT jhonyanacletosantos antitoxoplasmaantioxidantandcytotoxicactivitiesofpleopeltiscrassinervatafeetmoorehexanefraction
AT perlalopezcamacho antitoxoplasmaantioxidantandcytotoxicactivitiesofpleopeltiscrassinervatafeetmoorehexanefraction
AT ricardomondragonflores antitoxoplasmaantioxidantandcytotoxicactivitiesofpleopeltiscrassinervatafeetmoorehexanefraction
AT elisavegaavila antitoxoplasmaantioxidantandcytotoxicactivitiesofpleopeltiscrassinervatafeetmoorehexanefraction
AT gustavobasurtoislas antitoxoplasmaantioxidantandcytotoxicactivitiesofpleopeltiscrassinervatafeetmoorehexanefraction
AT monicamondragoncastelan antitoxoplasmaantioxidantandcytotoxicactivitiesofpleopeltiscrassinervatafeetmoorehexanefraction
AT elbacarrascoramirez antitoxoplasmaantioxidantandcytotoxicactivitiesofpleopeltiscrassinervatafeetmoorehexanefraction
AT normariverafernandez antitoxoplasmaantioxidantandcytotoxicactivitiesofpleopeltiscrassinervatafeetmoorehexanefraction
_version_ 1724971819072487424